A sialylated molecule that can prevent viral attachment to cellular receptors may limit the early stages of viral infection, in contrast to neuraminidase (NA) inhibition, which is believed to primarily act by limiting the release of new virions from virus-infected cells. This evidence concerns the gene XK and viral infectious disease.